Panipenem/betamipron

Panipenem/betamipron is a combination medication used in the treatment of various bacterial infections. It contains two active ingredients: panipenem, a carbapenem antibiotic, and betamipron, a renal dehydropeptidase inhibitor.

Etymology

The name "panipenem" is derived from the Greek words "pani-", meaning "all", and "penem", a suffix used in the names of many beta-lactam antibiotics. The name "betamipron" is a portmanteau of "beta", referring to its action on beta-lactamase enzymes, and "mipron", a suffix used in the names of many synthetic drugs.

Pharmacology

Panipenem is a broad-spectrum carbapenem antibiotic that works by inhibiting the synthesis of bacterial cell walls, leading to cell death. Betamipron is a renal dehydropeptidase inhibitor that protects panipenem from being metabolized and deactivated in the kidneys, thereby increasing its effectiveness.

Clinical Use

Panipenem/betamipron is used to treat a wide range of bacterial infections, including those caused by Gram-positive bacteria, Gram-negative bacteria, and anaerobic bacteria. It is particularly effective against infections caused by bacteria that are resistant to other antibiotics.

Side Effects

Common side effects of panipenem/betamipron include nausea, diarrhea, and skin rash. In rare cases, it can cause serious side effects such as seizures, severe allergic reactions, and Clostridium difficile-associated diarrhea.

Related Terms

• Carbapenem: A class of antibiotics to which panipenem belongs.
• Beta-lactam: A class of antibiotics that includes carbapenems, penicillins, and cephalosporins.
• Renal dehydropeptidase: An enzyme found in the kidneys that metabolizes certain drugs, including panipenem.